Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Intangibles (2020 - 2025)

Oncology Institute (TOI) has disclosed Intangibles for 5 consecutive years, with $14.0 million as the latest value for Q1 2025.

  • For the quarter ending Q1 2025, Intangibles changed N/A year-over-year to $14.0 million, compared with a TTM value of $14.0 million through Mar 2025, changed N/A, and an annual FY2024 reading of $14.8 million, down 17.28% over the prior year.
  • Intangibles was $14.0 million for Q1 2025 at Oncology Institute, down from $14.8 million in the prior quarter.
  • Across five years, Intangibles topped out at $18.2 million in Q4 2021 and bottomed at $14.0 million in Q1 2025.
  • Average Intangibles over 5 years is $16.6 million, with a median of $17.1 million recorded in 2023.
  • The sharpest move saw Intangibles decreased 0.3% in 2023, then fell 17.28% in 2024.
  • Year by year, Intangibles stood at $18.2 million in 2021, then dropped by 1.58% to $18.0 million in 2022, then fell by 0.3% to $17.9 million in 2023, then fell by 17.28% to $14.8 million in 2024, then decreased by 5.23% to $14.0 million in 2025.
  • Business Quant data shows Intangibles for TOI at $14.0 million in Q1 2025, $14.8 million in Q4 2024, and $16.4 million in Q2 2024.